Rich Tech Guys Fund Research to Discover Fountain of Youth | Pharmaguy's Insights Into Drug Industry News |

Technologists are famous for upending and redefining entire industries, from finance to media. Now, some of these same visionaries are targeting a much grander goal: extending life.


Oracle's Larry Ellison, Alphabet's Larry Page, billionaire investor Peter Thiel and CEO Jeff Bezos are among the entrepreneurs pouring money and resources into drugs and therapies designed to slow the effects of aging and its related illnesses.


If they're right, the average lifespan of 79 years will be a thing of the past, and humans could live for decades longer.


"The science is really good now," said Elad Gil, a tech entrepreneur who received a Ph.D. in biology from the Massachusetts Institute of Technology and currently invests in anti-aging start-ups. "It is at the point where there is enough evidence and data around these drugs and molecules."


Like many of his peers, Gil built his credibility on the internet by selling a company, Mixer Labs, to Twitter in 2009. He now sees opportunity in this next generation of biotechnology.


Start-ups targeting anti-aging drugs and therapies have raised $523 million in the last four years, according to CB Insights. Much of this market is still in the lab, with scientists testing therapies on mice. But longevity evangelists are targeting human trials within 18 months.